Cui LZ, Zhao YW, Pan Y, et al. Onco Targets Ther. 2017;10:5817–5826. The authors have advised that there is an error in Figure 5A on page 5823. During figure assembly, the Magnification 10x images for panels Control and PF562271 were switched in error. The correct Figure 5 is as follows. Figure 5 The influence of the FAK inhibitor PF562271 (PF) on the VP-16-induced repopulation of SKOV3 cells.Abbreviations: FAK, focal adhesion kinase; VP-16, etoposide phosphate; SD, standard deviation.Notes: (A) Representative images of the crystal violet staining assay of the receptor cells with the FAK inhibitor PF562271 (PF) added to the system. (B) The stained cells of the four groups in A were solubilized with 1 mL of 33% acetic acid and quanti...
In the original Figure 4G, two of the upper panels (His-iASPP(625-828)-FITC; the two rightmost panel...
Gurunathan S, Park JH, Han JW, Kim J. Int J Nanomedicine. 2015;10(1):4203–4223. It was bought...
This Article contains an error in the order of panels of Figure 1. Panels a, b, c, d and e should ap...
Obasi TC, Braicu C, Iacob BC, et al. Cancer Manag Res. 2018;10:5709–5724.On page 5717, there w...
Subsequent to the publication of the above article, the authors have realized that there were errors...
Sun J, Shen D, Gao Y, et al. Onco Targets Ther. 2020;13:7973– 7984. The authors have advised d...
Hu H, Dong Z, Wang X, et al. Onco Targets Ther. 2019;12:5163–5175. The authors have advised du...
Correction to: Scientific Reports https://doi.org/10.1038/srep32062, published online 31 August 201
Following publication of the original article [1], the authors reported an error in the labeling of ...
Zhou J, Zhang S, Fu G, et al. Onco Targets Ther. 2018;11:7125–7132. Author intended to show un...
Deng YR, Chen XJ, Chen W, et al. Cancer Manag Res. 2019;11:5835–5844. The authors have advised...
PHARMACOLOGY Correction for “CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malig...
[[abstract]]We would like to apply 3 corrections to our published paper [1]. The reason for the corr...
Tai Y, Zhang LH, Gao JH, et al. Cancer Manag Res. 2019;11:2831–2848. The authors have advised ...
This article has been corrected: In Figure 4B, the image of MDA-MB-231 cells expressing CSMD1 is an ...
In the original Figure 4G, two of the upper panels (His-iASPP(625-828)-FITC; the two rightmost panel...
Gurunathan S, Park JH, Han JW, Kim J. Int J Nanomedicine. 2015;10(1):4203–4223. It was bought...
This Article contains an error in the order of panels of Figure 1. Panels a, b, c, d and e should ap...
Obasi TC, Braicu C, Iacob BC, et al. Cancer Manag Res. 2018;10:5709–5724.On page 5717, there w...
Subsequent to the publication of the above article, the authors have realized that there were errors...
Sun J, Shen D, Gao Y, et al. Onco Targets Ther. 2020;13:7973– 7984. The authors have advised d...
Hu H, Dong Z, Wang X, et al. Onco Targets Ther. 2019;12:5163–5175. The authors have advised du...
Correction to: Scientific Reports https://doi.org/10.1038/srep32062, published online 31 August 201
Following publication of the original article [1], the authors reported an error in the labeling of ...
Zhou J, Zhang S, Fu G, et al. Onco Targets Ther. 2018;11:7125–7132. Author intended to show un...
Deng YR, Chen XJ, Chen W, et al. Cancer Manag Res. 2019;11:5835–5844. The authors have advised...
PHARMACOLOGY Correction for “CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malig...
[[abstract]]We would like to apply 3 corrections to our published paper [1]. The reason for the corr...
Tai Y, Zhang LH, Gao JH, et al. Cancer Manag Res. 2019;11:2831–2848. The authors have advised ...
This article has been corrected: In Figure 4B, the image of MDA-MB-231 cells expressing CSMD1 is an ...
In the original Figure 4G, two of the upper panels (His-iASPP(625-828)-FITC; the two rightmost panel...
Gurunathan S, Park JH, Han JW, Kim J. Int J Nanomedicine. 2015;10(1):4203–4223. It was bought...
This Article contains an error in the order of panels of Figure 1. Panels a, b, c, d and e should ap...